Drugmakers race to find a place in the next wave of obesity drugs
Summary
Drugmakers are betting they can crack into the obesity drug market that Novo Nordisk and Eli Lilly currently dominate.
Visit the original source for the full article
📖 Read article in English
💼 Related articles — Finance & Business
💼
Fox to buy streaming device maker Roku for $22 billion
Bruno Mars Ties One Of The Top Female Artists Of The Past Two Decades
💼
KFC leans into boneless chicken, new drinks as chain tries to regain market share
San Francisco Giants’ 3-Year Outfielder Leaves MLB After Slow Start
The $4 Billion Coffee Pod Business Faces Its Biggest Threat Yet
Obamacare’s Enrollment Figures Deserve A Closer Look
Purpose-Driven Principles for Long-Term Success
Athletics Send Braves’ Matt Olson Message As They Recruit For Las Vegas Move
Your Business Is Profitable—Do You Know Which Part?
Red Sox Cut Yankees’ Former First-Round Pick After Injury Setback
GDP says your region is thriving. But are people prospering?
Sports Podcasts Are Looking To Score That Golden Goooaalll!
AI Is Finally in Finance
Phillies Beatdown Recalls Trea Turner’s ‘Terrible’ Jacob Misiorowski Message
This AI Video Startup Grew to 24 Million Users in Just One Year. Here’s How
Don’t Build A Combatant Command Around A Tool